Discordance between beliefs and recommendations of gynecologic oncologists in ovarian cancer management

L. Chen, L. A. Learman, V. Weinberg, C. B. Powell

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: The purpose of this study was to determine how physician experts make decisions for clinical scenarios in ovarian cancer and describe a profile of factors reported to influence treatment decisions. Methods: A questionnaire was sent to Full Members of the Society of Gynecologic Oncologists regarding surgery and chemotherapy for scenarios of primary and recurrent ovarian cancer. Results: In a scenario of primary presentation, 94% of respondents chose a treatment of tumor resection over chemotherapy. Despite the preference for surgery in a clinical scenario, 50% agreed with a statement that neoadjuvant chemotherapy is equivalent to primary surgery. In a scenario of recurrent disease, a comparable number of respondents chose a treatment of secondary cytoreductive surgery (45%) versus direct retreatment with chemotherapy (49%). Those choosing surgery responded that they believed in extensive surgery to achieve optimal cytoreduction. Most (62%) respondents described themselves as collaborative in treatment planning, yet only 24% reported that patient preference strongly influences their decision making. Conclusions: Although a plan for primary cytoreduction is favored, in specific scenarios, views were divided for the role of neoadjuvant chemotherapy. For a recurrent disease scenario, support was divided between secondary cytoreductive surgery and direct retreatment with chemotherapy. Further clinical research is necessary to minimize the discordance between physician beliefs and recommendations.

Original languageEnglish (US)
Pages (from-to)1055-1062
Number of pages8
JournalInternational Journal of Gynecological Cancer
Volume14
Issue number6
DOIs
StatePublished - Nov 2004
Externally publishedYes

Fingerprint

Ovarian Neoplasms
Drug Therapy
Retreatment
Physicians
Patient Preference
Therapeutics
Oncologists
Decision Making
Surveys and Questionnaires
Research
Neoplasms

Keywords

  • Chemotherapy
  • Decision making
  • Ovarian cancer
  • Surgery

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology
  • Cancer Research

Cite this

Discordance between beliefs and recommendations of gynecologic oncologists in ovarian cancer management. / Chen, L.; Learman, L. A.; Weinberg, V.; Powell, C. B.

In: International Journal of Gynecological Cancer, Vol. 14, No. 6, 11.2004, p. 1055-1062.

Research output: Contribution to journalArticle

Chen, L. ; Learman, L. A. ; Weinberg, V. ; Powell, C. B. / Discordance between beliefs and recommendations of gynecologic oncologists in ovarian cancer management. In: International Journal of Gynecological Cancer. 2004 ; Vol. 14, No. 6. pp. 1055-1062.
@article{f5843b3e9d464f32b70cbdd0ec45b462,
title = "Discordance between beliefs and recommendations of gynecologic oncologists in ovarian cancer management",
abstract = "Purpose: The purpose of this study was to determine how physician experts make decisions for clinical scenarios in ovarian cancer and describe a profile of factors reported to influence treatment decisions. Methods: A questionnaire was sent to Full Members of the Society of Gynecologic Oncologists regarding surgery and chemotherapy for scenarios of primary and recurrent ovarian cancer. Results: In a scenario of primary presentation, 94{\%} of respondents chose a treatment of tumor resection over chemotherapy. Despite the preference for surgery in a clinical scenario, 50{\%} agreed with a statement that neoadjuvant chemotherapy is equivalent to primary surgery. In a scenario of recurrent disease, a comparable number of respondents chose a treatment of secondary cytoreductive surgery (45{\%}) versus direct retreatment with chemotherapy (49{\%}). Those choosing surgery responded that they believed in extensive surgery to achieve optimal cytoreduction. Most (62{\%}) respondents described themselves as collaborative in treatment planning, yet only 24{\%} reported that patient preference strongly influences their decision making. Conclusions: Although a plan for primary cytoreduction is favored, in specific scenarios, views were divided for the role of neoadjuvant chemotherapy. For a recurrent disease scenario, support was divided between secondary cytoreductive surgery and direct retreatment with chemotherapy. Further clinical research is necessary to minimize the discordance between physician beliefs and recommendations.",
keywords = "Chemotherapy, Decision making, Ovarian cancer, Surgery",
author = "L. Chen and Learman, {L. A.} and V. Weinberg and Powell, {C. B.}",
year = "2004",
month = "11",
doi = "10.1111/j.1048-891X.2004.14602.x",
language = "English (US)",
volume = "14",
pages = "1055--1062",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Discordance between beliefs and recommendations of gynecologic oncologists in ovarian cancer management

AU - Chen, L.

AU - Learman, L. A.

AU - Weinberg, V.

AU - Powell, C. B.

PY - 2004/11

Y1 - 2004/11

N2 - Purpose: The purpose of this study was to determine how physician experts make decisions for clinical scenarios in ovarian cancer and describe a profile of factors reported to influence treatment decisions. Methods: A questionnaire was sent to Full Members of the Society of Gynecologic Oncologists regarding surgery and chemotherapy for scenarios of primary and recurrent ovarian cancer. Results: In a scenario of primary presentation, 94% of respondents chose a treatment of tumor resection over chemotherapy. Despite the preference for surgery in a clinical scenario, 50% agreed with a statement that neoadjuvant chemotherapy is equivalent to primary surgery. In a scenario of recurrent disease, a comparable number of respondents chose a treatment of secondary cytoreductive surgery (45%) versus direct retreatment with chemotherapy (49%). Those choosing surgery responded that they believed in extensive surgery to achieve optimal cytoreduction. Most (62%) respondents described themselves as collaborative in treatment planning, yet only 24% reported that patient preference strongly influences their decision making. Conclusions: Although a plan for primary cytoreduction is favored, in specific scenarios, views were divided for the role of neoadjuvant chemotherapy. For a recurrent disease scenario, support was divided between secondary cytoreductive surgery and direct retreatment with chemotherapy. Further clinical research is necessary to minimize the discordance between physician beliefs and recommendations.

AB - Purpose: The purpose of this study was to determine how physician experts make decisions for clinical scenarios in ovarian cancer and describe a profile of factors reported to influence treatment decisions. Methods: A questionnaire was sent to Full Members of the Society of Gynecologic Oncologists regarding surgery and chemotherapy for scenarios of primary and recurrent ovarian cancer. Results: In a scenario of primary presentation, 94% of respondents chose a treatment of tumor resection over chemotherapy. Despite the preference for surgery in a clinical scenario, 50% agreed with a statement that neoadjuvant chemotherapy is equivalent to primary surgery. In a scenario of recurrent disease, a comparable number of respondents chose a treatment of secondary cytoreductive surgery (45%) versus direct retreatment with chemotherapy (49%). Those choosing surgery responded that they believed in extensive surgery to achieve optimal cytoreduction. Most (62%) respondents described themselves as collaborative in treatment planning, yet only 24% reported that patient preference strongly influences their decision making. Conclusions: Although a plan for primary cytoreduction is favored, in specific scenarios, views were divided for the role of neoadjuvant chemotherapy. For a recurrent disease scenario, support was divided between secondary cytoreductive surgery and direct retreatment with chemotherapy. Further clinical research is necessary to minimize the discordance between physician beliefs and recommendations.

KW - Chemotherapy

KW - Decision making

KW - Ovarian cancer

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=10044268451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044268451&partnerID=8YFLogxK

U2 - 10.1111/j.1048-891X.2004.14602.x

DO - 10.1111/j.1048-891X.2004.14602.x

M3 - Article

VL - 14

SP - 1055

EP - 1062

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 6

ER -